# GLORIA-AF Registry Program (Phase I)

> **NCT01428765** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1096 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01428765
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 1096 (ACTUAL)
- **Last updated:** 2014-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01428765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01428765, "GLORIA-AF Registry Program (Phase I)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01428765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*